The rs1801133 polymorphism in the MTHFR exon 4 reduces the MTHFR activity and leads to hyperhomocysteinemia [59], a risk factor for atherosclerosis, inflammation, and endothelial dysfunction [60]. Here, MTHFR is linked to hyperhomocysteinemia.